A specialty pharmacist discusses the added communication and support—including manufacturers working with patient groups—that foster adherence among smaller patient populations.
Many patients with rare diseases use temperature-controlled therapies to manage symptoms. With smaller patient populations and batch volumes, special handling is often required to ensure these expensive drugs arrive safely. Brandon Salke, Pharm.D, is pharmacist-in-charge at Optime Care, a specialty pharmacy, distribution, and patient management organization focusing on rare, orphan and ultra-orphan products. He discusses that while not all patients in these populations have mobility issues, these therapies have different last mile and two-way communication practices compared to traditional drugs.
To read more, Click Here.
